Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from StemCell Institute ( (JP:7096) ).
StemCell Institute Inc. has entered a joint venture with BIG RAINBOW INVESTMENT PTE. LTD., the family office of Sinar Mas Group, to expand its cell banking business in Southeast Asia. This strategic partnership aims to leverage StemCell’s expertise and the local networks of Sinar Mas Group to strengthen its presence and achieve sustainable growth in the region, with plans to explore related regenerative medicine services.
More about StemCell Institute
StemCell Institute Inc. operates in the biotechnology industry, specializing in cell storage services using cord blood and perinatal tissue. As a leading company in Japan with a dominant market share, it focuses on expanding its cell banking business into the Southeast Asian market.
Average Trading Volume: 38,772
Technical Sentiment Signal: Sell
Current Market Cap: Yen9.73B
For an in-depth examination of 7096 stock, go to TipRanks’ Overview page.